Research points toward potential immune therapies for individuals at high risk for RSV and flu, two common respiratory viruses. This could benefit infants, children, the elderly and persons with compromised immune systems.
Research points toward potential immune therapies for individuals at high risk for RSV and flu, two common respiratory viruses. This could benefit infants, children, the elderly and persons with compromised immune systems.